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Background. Susceptibility to coinfections in human immunodeficiency virus (HIV)-infected patients remains increased 
despite antiretroviral therapy (ART). To elucidate mechanisms involved in immune reconstitution, we studied immune activation, 
immune exhaustion, and HIV- and copathogen-specific T-cell responses in children before and after ART.
Methods. We prospectively enrolled 25 HIV-infected children to study HIV-, cytomegalovirus (CMV)-, and tuberculosis (TB)-
specific T-cell responses before and 1 year after initiation of ART using intracellular cytokine (interleukin-2, interferon-γ, tumor 
necrosis factor-α) staining assays after in vitro stimulation. We further measured expression of activation, immune exhaustion, and 
memory phenotype markers and studied proliferative responses after antigen stimulation.
Results. We observed differential, pathogen-specific changes after 1 year of ART in cytokine profiles of CD4 T-cell responses 
that were associated with shifts in memory phenotype and decreased programmed cell death 1 (PD-1) expression. The proliferative 
capacity of HIV- and PPD-specific responses increased after 1 year of ART. Of note, the recovery of CMV- and TB-specific responses 
was correlated with a decrease in PD-1 expression (r = 0.83, P = .008 and r = 0.81, P = .0007, respectively).
Conclusions. Reconstitution of immune responses on ART is associated with alterations in T-cell phenotype, function, and 
PD-1 expression that are distinct for HIV, TB, and CMV. The PD-1 pathway represents a potential target for immunotherapy in HIV-
infected patients on ART with insufficient immune reconstitution.
Keywords. antiretroviral therapy; cytomegalovirus; HIV; tuberculosis.
Untreated chronic human immunodeficiency virus (HIV) infec-
tion is characterized by CD4 T-cell depletion, systemic immune 
activation [1], and immune exhaustion [2, 3] that ultimately 
result in immunodeficiency. In addition to a quantitative loss of 
CD4+ T cells, cellular immunity in progressive HIV infection is 
further impaired qualitatively by blunted effector cytokine pro-
files and reduced proliferative capacity of HIV- [4] and copath-
ogen-specific T cells [5–10] resulting in increased susceptibility 
to or disease manifestation of copathogens such as cytomegalo-
virus (CMV) and Mycobacterium tuberculosis (MTB).
Although in antiretroviral therapy (ART)-treated adults 
reconstitution of T-cell responses against MTB [6, 11–13] and 
CMV [10, 14, 15] appears to be limited, previous studies have 
shown greater potential for overall immune reconstitution in 
children on ART [16, 17], which has partly been attributed to 
increased thymic output [18, 19]. However, most of these stud-
ies focused on quantitative immune recovery, whereas data on 
functional recovery of cellular immunity remain scarce [20–22].
Coinfections with CMV and MTB result in high morbid-
ity and mortality in HIV-infected children especially on the 
African continent, and therefore it is of great importance to 
strengthen our knowledge of immune reconstitution against 
these pathogens in this population. In this prospective lon-
gitudinal cohort study, we examine memory differentiation, 
immune activation, immune exhaustion, and T-cell responses 
before and 1 year after ART in HIV-infected children compared 
to HIV-uninfected children. We show that reconstitution of 
T-cell function on ART differs by pathogen specificity and is 
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associated with shifts in memory phenotype and programmed 
cell death 1 (PD-1) expression.
MATERIALS AND METHODS
Study Subjects
Antiretroviral therapy-naive vertically HIV-infected children 
and adolescents were recruited at the Ithembalabantu Clinic in 
Umlazi, Durban, South Africa. Participants were initiated on 
ART according to current South African guidelines and followed 
up quarterly for 1 year. Based on sample availability, 25 partici-
pants with undetectable viral load levels at the 1-year visit were 
selected for this study. Three of the participants had a history of 
tuberculosis (TB) disease and were excluded for the analysis of 
purified peptide derivative (PPD)-specific immune responses. 
No participants displayed signs or symptoms of immune reconsti-
tution inflammatory syndrome. In addition, 22 HIV-uninfected 
siblings (median age, 12.9 years; interquartile range, 8.8–14.95) 
were studied. Ethical approval for this study was obtained from 
the University of KwaZulu-Natal Ethics Review Board and the 
Oxford Research Ethics Committee. For all study participants, 
written informed consent was given by their caregivers.
CD4 Count and Viral Load Measurements
Plasma HIV viral load levels were determined using the NucliSens 
version 2.0 (BioMérieux), and absolute CD4 T-cell counts and 
percentage (CD4%) were measured by flow cytometry at the 
Global clinical and viral laboratory (Amanzimtoti, South Africa).
Cytomegalovirus (CMV) Serology and Quantitative CMV-Polymerase Chain 
Reaction
Cytomegalovirus serology and polymerase chain reaction test-
ing were performed at the Max von Pettenkofer Institute (LMU 
München, Munich, Germany).
Sample Preparation
Peripheral blood mononuclear cells (PBMCs) were isolated 
from ethylenediaminetetraacetic acid-blood by Ficoll-Hypaque 
density gradient centrifugation and used directly or cryopre-
served in 90% fetal calf serum (FCS) plus 10% dimethyl sulf-
oxide in liquid nitrogen. Cryopreserved PBMCs were thawed 
and rested in medium (Roswell Park Memorial Institute 1640 
medium [Sigma-Aldrich] plus 10% FCS and 50 units penicillin/
streptomycin) for 6 hours before antigen stimulation.
Antigen Stimulation
The PBMCs were adjusted to 1 million cells/stimulation and stim-
ulated using a pool of 66 peptides covering the HIV-1 Clade C 
consensus Gag protein (18-mers overlapping by 10 amino acids) 
at 2 μg/mL final concentration, a pool of 138 peptides covering 
the CMV pp65 protein (15-mers overlapping by 11 amino acids; 
NIH AIDS Reagent Program) at 2  μg/mL, MTB PPD (Statens 
Serum Institute) at 10 μg/mL, and Staphylococcal enterotoxin B 
(SEB; Sigma-Aldrich) at 1 μg/mL as positive control or medium 
only. The PBMCs were stimulated overnight (12–16 hours) at 
37°C in the presence of costimulatory antibodies anti-CD28 and 
anti-CD49d (BD Bioscience) at 1 μg/mL. After 1-hour incuba-
tion, Brefeldin A (Sigma-Aldrich) was added at 10 μg/mL.
Surface and Intracellular Staining for Flowcytometry
Cell surface and intracellular cytokine staining were performed 
as previously described [23]. In brief, after cell surface staining, 
cells were fixed and permeabilized using BD Cytofix/Cytoperm 
Buffer and stained for intracellular cytokines with antibodies in 
BD Perm/Wash Buffer (BD Biosciences). Reagents and flowcy-
tometry panels are shown in Supplementary Table 1. Samples 
were acquired on a BD LSRII and data were analyzed using 
FlowJo version 10.0.7 (Tree Star). Polyfunctional cytokine pro-
files were analyzed using Pestle version 1.7 and Spice version 
5.35 [24]. Data processing and detailed gating strategies are pre-
sented in Supplementary Figures 1–4.
Carboxyfluorescein Diacetate Succinimidyl Ester Proliferation Assays
Carboxyfluorescein diacetate succinimidyl ester (CFSE)-
dilution assays were performed as previously described [25]. 
Only samples with less than 0.2% CFSElow CD4 and CD8 T 
cells in the unstimulated control were considered for analysis. 
Antigen stimulations were performed using the peptide pools 
and concentrations described above and phytohemagglutinin 
(PHA) at a final concentration of 2 μg/mL.
Statistical Analysis
Statistical comparisons between groups were based on Mann-
Whitney U and Wilcoxon rank-sum tests for unmatched and 
paired samples, respectively. Spearman rank tests were used for 
correlations. All of these statistical analyses were performed 
using GraphPad Prism version 6.0c (GraphPad Software Inc.). 
Statistical comparisons of multicomponent distributions of 
polyfunctional profiles as shown in the pie charts were done by 
permutation tests based on χ2 analysis using Spice version 5.35 
as previously described [24].
RESULTS
Effects of Antiretroviral Therapy on T-Cell Memory Profiles, Activation, and 
Exhaustion
To better understand the impact of ART on immune reconsti-
tution at young age, we studied 25 HIV-infected children and 
adolescents before and 1 year after initiation of ART. Clinical 
characteristics of study participants are summarized in Table 1 
and Supplementary Table  2. Participants were selected based 
on virologic suppression at the 1-year study visit. The mean in-
crease in absolute CD4 count was 324 (IQR, 121–530) and the 
mean increase in CD4% was 10.6 (IQR, 5.0–15.2) (Figure 1A). 
Reconstitution of the CD4 T-cell compartment was associated 
with an increased frequency of T-naive CD4 T cells (Figure 1B), 
but not other CD4 memory subsets (data not shown). We also 
observed an increase in the frequency of naive CD8 T cells 
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(CD45RA+CCR7+) accompanied by a decrease of central and 
effector memory CD8 T cells (Supplementary Figure 5a).
There was no significant decrease in CD4 and CD8 T-cell 
activation across the cohort but persistently elevated activation 
levels, characterized by HLA-DR and CD38 expression [26], 
compared with HIV-uninfected controls after 1 year on ther-
apy (Figure  1C and Supplementary Figure  5b). In the analy-
sis by memory subset, a significant decrease of activation was 
Table 1. Summary Clinical Characteristics of Study Participants (n = 25)a
 
  Pre-ART Post-ART
Age
(Years)
Male/
Female
CD4 Count
(Cells/mm3) CD4%
Viral Load
(Copies/mL)
CD4 Count
(Cells/mm3) CD4%
Viral Load
(Copies/mL)
Median 7.6 11/24 397 17 120 000 692 29 All <20
IQR 4.5–11.0  183–800 7.5–28 20 798–515 000 494–1033 19–36  
Abbreviations: ART, antiretroviral therapy; IQR, interquartile range.
aMedian values and IQRs are shown for each clinical parameter before and after 1 year of ART: pre-ART, baseline study visit on the day of ART-initiation; post-ART, study visit 1 year after 
ART-initiation.
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Figure 1. Effect of antiretroviral therapy (ART) on T-cell activation, programmed cell death 1 (PD-1) expression, and memory phenotype. (A) Suppression of viremia and 
recovery of CD4% after 1 year of ART in the 25 human immunodeficiency virus (HIV)-infected children selected for this study. Medians are shown as horizontal bars. (B) 
Representative fluorescence-activated cell sorting (FACS) data showing CD45RA and CCR7 expression of CD4 T cells of child 205-33-0015-1 before (top dot plot; CD4 count: 
35 cells/mm3, CD4%: 2%, viral load: 25910 cp/mL) and after 1 year of ART ([bottom dot plot] CD4 count, 692 cells/mm3; CD4%, 16%; viral load, <20 cp/mL). Middle panel 
shows the frequency of naive (CD45RA+CCR7+) CD4 T cells in HIV-infected children before and 1 year after ART compared to HIV-uninfected children. The fold increase of 
the naive CD4 T-cell population (frequency of naive CD4 T cells after 1 year of ART/frequency of naive CD4 T cells before ART) correlates with the fold increase of CD4% 
(CD4% after 1 year of ART/CD4% before ART). (C) Representative FACS data showing CD38 and HLA-DR expression of CD4 T cells in an HIV-uninfected child (top panel) 
compared with child 205-33-0061-1 after 1 year of ART ([bottom panel] CD4 count, 511 cells/mm3; CD4%, 15%; viral load, <20 cp/mL). Frequencies of activated CD4+ T cells 
(CD38+HLA-DR+) of HIV-infected children before and after 1 year of ART are shown in comparison with HIV-uninfected children. (D) Representative FACS data for PD-1-
expression of CD4 T cells of child 205-33-0061-1 before ([top panel] CD4 count, 251 cells/mm3; CD4%, 9%; viral load, 540000 cp/mL) and after 1 year of ART ([bottom panel] 
CD4 count, 511 cells/mm3; CD4%, 15%; viral load, <20 cp/mL). Frequencies of PD-1+ CD4 T cells are shown for HIV-infected children before and after ART and in comparison 
with HIV-uninfected children. Correlation between the fold decrease of PD-1high CD4 T cells (frequency of PD-1
+ CD4 T cells before ART/frequency of PD-1+ CD4 T cells after 
ART) and activated CD4 T cells after 1 year of ART (frequency of CD38+HLA-DR+ CD4 T cells before/frequency of CD38+HLA-DR+ CD4 T cells after ART). Statistical comparisons 
between groups are based on Mann-Whitney U and Wilcoxon rank-sum tests for unmatched and paired samples, respectively (A–D). Spearman rank tests are shown for 
correlations (B and D) (*, P < .05; **, P < .01; ***, P < .001; ****, P < .0001).
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observed only for CD4 and CD8 central memory T (Tcm) cells 
(Supplementary Figure 5b).
In contrast, although PD-1 expression was strongly correlated 
with activation (CD38 and HLA-DR expression) of CD4 T cells 
at baseline (r = 0.59, P = .001; Supplementary Figure 5c), PD-1 
expression was significantly reduced in CD4 and CD8 T cells 
after 1 year of ART (Figure 1D and Supplementary Figure 5d). 
Because PD-1 expression has been reported to vary between 
memory subsets [27], we measured PD-1 expression on differ-
ent subsets to rule out confounding effects of shifts in mem-
ory differentiation on ART. The PD-1 expression was reduced 
across all CD4 subsets, but it persisted at higher levels than in 
HIV-uninfected controls. A  similar pattern was observed for 
PD-1 expression on CD8 T cells (Supplementary Figure 5d). 
The decrease of CD4 T-cell PD-1 expression after 1 year of ART 
was related to the decrease of CD4 T-cell activation (Figure 1D).
Changes in Functional Profiles and Memory Phenotype of Human 
Immunodeficiency Virus-Specific CD4 T Cells on Antiretroviral Therapy 
We next compared cytokine profiles of Gag-specific T cells 
before and after 1 year of ART. Gag-specific CD4 responses that 
were detected in 21 subjects at both time points were considered 
for this comparison. We observed a shift in cytokine patterns for 
the Gag-specific CD4 T-cells response, with a reduction of inter-
feron (IFN)-γ monoproducing cells (P =  .001) and increased 
proportions of cells responding with all 3 cytokines (P =  .01) 
(Figure 2A). Although the proportions of cells responding with 
IFN-γ decreased (P =  .0025), the fraction of CD4 T cells pro-
ducing interleukin (IL)-2 upon Gag stimulation increased after 
1 year of ART (P = .0014) (Figure 2B). Because varying cytokine 
profiles have been described for different CD4 T-cell memory 
subsets [28], we hypothesized that these changes in function-
ality were due to shifts in memory subsets and determined the 
memory phenotype of cytokine-positive cells in a subset of 11 
children (Figure 2C). There was a shift of Gag-specific CD4 T 
cells from effector memory (P =  .024) towards central mem-
ory phenotype (P = .002). This increased proportion of Tcm of 
the total response was correlated with the decrease of IFN-γ-
secreting cells (r = −0.73, P = .013) (Figure 2D). Overall, these 
data show that ART results in changes of memory phenotype 
of HIV-specific CD4 T-cell responses that is associated with 
altered functional profiles. Of note, we did not observe signif-
icant changes in the magnitude or cytokine profiles of Gag-
specific CD8 T cells or in the magnitude of CD4 Gag responses 
(Supplementary Figure 6a–c).
Limited Reconstitution of Purified Peptide Derivative-Specific T-Cell 
Responses on Antiretroviral Therapy
To better understand the increased susceptibility of HIV-
infected children to TB even despite effective ART, we com-
pared PPD-specific T-cell functionality before versus after ART 
and relative to HIV-uninfected children. Three participants 
were excluded for this analysis because of TB history. We 
detected PPD-specific responses in 15 of 22 HIV-infected 
children and in 19 of 22 HIV-uninfected children. Compared 
to HIV-uninfected children, HIV-infected children showed 
reduced frequencies of polyfunctional CD4 T cells responding 
to PPD with lower proportions of cells producing all 3 Th1 
effector cytokines tested (P =  .0125), and this qualitative al-
teration persisted after 1 year of ART (P = .02) (Figure 3A). In 
particular, the proportion of cells responding with tumor ne-
crosis factor-α was reduced in CD4+ and CD8+ T cells of HIV-
infected children (P = .0002 and P = .049, respectively), but it 
recovered to a certain degree upon ART (P = .01 and P = .0085) 
(Figure 3B). Other than this, we observed no significant dif-
ferences in functional profiles of PPD-responding CD8 T cells 
between HIV-uninfected children and HIV-infected children 
before or after ART (Supplementary Figure 7a and b). Similar 
to our observations for the Gag-specific CD4 response, there 
was a shift of the PPD response from effector memory phe-
notype to central memory phenotype (Figure  3C). Of note, 
although we observed no concordant increase or decrease 
in the magnitude of the CD4 or CD8 response against PPD 
(Supplementary Figure 7c), the fold change of the frequency 
of PPD-responding CD4 T cells after ART was strongly cor-
related with the decrease in PD-1 expression on CD4 effector 
memory T cells (r = 0.833, P =  .008; Figure 3D). It is inter-
esting to note that a similar association was observed for the 
fold change of the number of PPD-responding CD4 T cells per 
mm3 blood and the change of PD-1 expression on T effector 
memory (Tem) CD4 T cells after ART (r = 0.85, P =  .0061; 
Supplementary Figure 7d), but not for PD-1 expression of the 
bulk CD4 population or of other CD4 memory subsets. These 
correlations were still significant after Bonferroni adjustment 
for multiple comparisons.
Effects of Antiretroviral Therapy on Cytomegalovirus-Specific T-Cell 
Responses
To further study distinct reconstitution of copathogen immu-
nity, we evaluated CMV-specific responses before and after 
ART and in comparison to HIV-uninfected children. All chil-
dren tested seropositive for anti-CMV immunoglobulin (Ig)
G. Limited sample availability restricted the analyses of CMV 
T-cell responses to 19 of the HIV-infected children. We detected 
CMV-specific CD8 T-cell responses in all HIV-infected and 
-uninfected children, whereas CD4 T-cell responses against 
CMV were only detected in 15 of 19 HIV-infected before ART 
but in all children after 1 year of ART and in the HIV-uninfected 
controls. It is interesting to note that CMV-deoxyribonucleic 
acid was only detected in the serum of 4 HIV-infected children 
before ART at low levels (617, 170, <90, and <90 cp/mL). Two of 
these children had undetectable CMV-specific CD4 responses, 
and the other 2 had low numbers of responding cells (lowest 
quartile) (Figure 4A).
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In contrast to the Gag- and PPD-specific CD4 response, 
for which we observed no increase in the absolute number of 
antigen-specific cells, the number of CMV-specific CD4 T cells 
per mm3 of blood expanded significantly on ART (P =  .0005) 
(Figure 4A). Of note, this increase in absolute counts of CMV-
responding CD4 T cells was not merely correlated with higher 
CD4 counts in children on ART (absolute CMV response vs 
CD4 count before ART: r = 0.1, P =  .67; after ART: r = 0.19, 
P = 0.43) nor with the increase of CD4 count (fold change of 
absolute CMV response vs fold change of CD4 count: r = 0.16, 
P = .58, Spearman rank tests). However, similar to the PPD re-
sponse, this change in absolute magnitude was strongly cor-
related with a decrease of PD-1 expression on Tem CD4 T cells 
(r = 0.81, P =  .0007), indicating the association between im-
mune exhaustion and reconstitution of copathogen-specific 
responses on ART (Figure 4A).
The functional profile of CMV-specific CD4 responses 
varied between HIV-infected and -uninfected children and 
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Figure 2. Changes in functional profiles correlate with shifts in memory phenotype of human immunodeficiency virus (HIV)-specific CD4 T cells on antiretroviral therapy 
(ART). (A) Comparison of HIV-1 Gag-reactive CD4 T cells of 21 children before and after 1 year of ART. Each slice of the pie chart represents the average relative proportions of 
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changed after 1  year of ART (Figure  4B and C). Compared 
to HIV-uninfected children, the proportion of CMV-specific 
CD4 T cells responding with IFN-γ was decreased in HIV-
infected children (P = .029) and remained lower after 1 year of 
ART (P = .051) (Figure 4D). In the CD8 response, the fraction 
of IFN-γ-producing cells was markedly increased in children 
on ART compared to before ART (P  =  .0012) and HIV-
uninfected children (P = .0007) (Figure 4D and Supplementary 
Figure 8). Although the memory phenotype of CMV-specific 
CD4 T cells did not change significantly, the proportion of 
CMV-specific CD8 T cells with Temra memory phenotype 
(CD45RA+CCR7−) increased on ART (P = .0161) (Figure 4D). 
It is interesting to note that longitudinal studies of primary 
CMV infection have shown that CD45RA re-expression of 
CD8 Tem (CD45RA−CCR7−) to the CD45RA+CCR7− Temra 
phenotype increased progressively over time and correlated 
with control of viremia [29].
Recovery of T-Cell Proliferative Capacity on Antiretroviral Therapy
We next hypothesized that the reduction in PD-1 expression 
and change in memory phenotypes of CD4 and CD8 T cells 
on ART would result in reconstitution of T-cell proliferative ca-
pacity. Therefore, we assessed proliferative responses in a CFSE 
dilution assay before and after ART and compared the responses 
to HIV-uninfected controls. The proliferative capacity of CD4 
and CD8 T cells upon mitogen (PHA) stimulation was signif-
icantly reduced in HIV-infected children compared to HIV-
uninfected children and recovered partially on ART (Figure 5A 
and B). The proliferative response of Gag-specific CD4 and 
CD8 T cells increased after 1 year on ART (Figure 5A and B). 
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It is interesting to note that for the CD4 PPD-specific response, 
we observed decreased proliferative capacity in HIV-infected 
children that only incompletely recovered on ART. In contrast, 
no significant changes were observed for the PPD-specific or 
CMV-specific responses of CD8 T cells in respect to HIV infec-
tion or treatment status (Figure 5A and B).
DISCUSSION
Antiretroviral therapy potently suppresses viral replication and 
results in robust quantitative replenishment of CD4 T cells in 
most HIV-infected children. However, the extent and mecha-
nisms of qualitative recovery of T-cell function remain unclear. 
In this prospective observational cohort study, we examine the 
reconstitution of T-cell responses against HIV, CMV, and MTB 
of 25 HIV-infected children in response to ART. Our main 
findings were that some of the functional changes of T-cell 
responses coincided with a reduction of PD-1 expression and 
shifts in memory phenotype, but that distinct patterns of im-
mune reconstitution were observed for individual pathogens.
In children, de novo production of naive cells by the thymus 
[18, 30] is believed to allow for greater potential for success-
ful immune reconstitution compared with adults. In adults, the 
reduced T-cell receptor repertoire due to loss of CD4 T cells during 
untreated infection may remain truncated if the increase in CD4 
count mainly stems from residual cell proliferation and survival 
[19]. In our study, the recovery of CD4% was strongly correlated 
with an increase in the frequency of naive CD4 T cells, indicating 
replenishment of the CD4 compartment by active thymopoiesis at 
a young age. Apart from age, the degree of immune reconstitution 
is also influenced by other critical factors such as baseline CD4 
count [31], immune activation [26], immune exhaustion [32], and 
the maturation state of antigen-specific cells [11].
Persistent antigen exposure in combination with the proin-
flammatory cytokine milieu in untreated HIV infection drives 
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the expansion of effector T-cell populations. Consistent with 
previous reports in HIV-infected children [21] and a recent 
cross-sectional cohort study from our group [33], we demon-
strate in this study that the HIV-specific CD4 T-cell responses 
in untreated children mainly consist of IFN-γ-monoproducing 
cells showing reduced polyfunctionality with a predominant 
loss of IL-2 responses reflecting the characteristic cytokine pro-
file of effector T cells [23, 28]. After viral suppression by 1 year 
of ART, the HIV-specific CD4 response shifted towards central 
memory phenotype in association with increased polyfunc-
tionality and proliferative capacity, the representative features 
of this memory subset [34]. These observations are consistent 
with a contraction of the effector response and formation of a 
persistent central memory compartment as proposed in models 
of memory T-cell development after antigen removal [35]. Of 
note, the changes we observed for the HIV-specific CD4 T-cell 
responses in this study are consistent with previous reports [21, 
33] but were more pronounced than previously reported for 
adults [36]. Children infected with HIV are therefore an inter-
esting patient population in regards to potential immunother-
apeutic interventions with the goal of inducing potent T-cell 
responses to achieve a functional cure after treatment interrup-
tion [37].
Globally, TB is the leading cause of death among people living 
with HIV, and the risk to develop active TB remains severalfold 
higher in HIV-infected patients, even despite successful ART 
with full recovery of CD4 counts [38]. Although clear immune 
correlates of protection remain elusive, there is compelling 
evidence for a fundamental role of T-cell responses in the suc-
cessful immune control of TB infection [39]. Mycobacterium 
tuberculosis-specific CD4 T cells from patients with active TB 
disease exhibit reduced polyfunctionality [40], terminally dif-
ferentiated memory phenotypes [41], impaired proliferative 
capacity [40], and higher levels of PD-1 expression [42] com-
pared with patients without active TB disease. In HIV-infected 
patients, TB-specific CD4 T cells are depleted early after infection 
[5] and show functional alterations with decreased polyfunction-
ality and proliferative capacity [8, 12]. Consistent with previous 
reports in adults [6, 12–14], we only observed modest changes 
in cytokine profiles of PPD-specific T cells in children on ART 
with persistently decreased frequencies of polyfunctional CD4 T 
cells compared with HIV-uninfected children. However, the role 
of polyfunctional TB-specific CD4 T-cell responses in TB disease 
remains highly controversial (reviewed in [39]).
A significant cofactor in HIV disease with an influence on 
immune activation and dysregulation is CMV coinfection, in 
particular in sub-Saharan Africa, where almost all children ac-
quire CMV early in life [43]. The frequency and function of 
CMV-specific CD4 T cells in HIV-infected hosts are dimin-
ished and only partially restored upon ART [10, 15], which is 
of particular relevance because, in addition to direct antiviral 
activity, CMV-specific CD4 T-cell responses are needed to sus-
tain effective CD8 T-cell responses [44]. In our study, similar to 
the responses against TB, the change in the absolute magnitude 
of the CD4 response against CMV was strongly correlated to a 
decrease of PD-1 expression.
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Figure 5. Recovery of T-cell proliferative capacity in human immunodeficiency virus (HIV)-infected children on antiretroviral therapy (ART). (A) Representative fluores-
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proliferative CD4 and CD8 T-cell responses of HIV-infected children (n = 9) before (red dots) and after ART (blue dots) and relative to HIV-uninfected children (green dots, 
n = 6). Medians are shown as horizontal bars. Statistical comparisons between groups are based on Mann-Whitney U and Wilcoxon rank-sum tests for unmatched and paired 
samples, respectively (*, P < .05; **, P < .01; ***, P < .001).
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The immunoregulatory molecule PD-1 has been identified as 
a major factor in the complex network of molecular events that 
results in immune exhaustion in HIV infection [2]. Likewise, in 
CMV infection, increased PD-1 expression on T cells results in 
functional exhaustion with diminished cytokine responses and 
decreased proliferative capacity [45, 46]. Recent studies also 
highlighted the role of the PD-1 pathway in TB disease, showing 
increased expression levels of PD-1 in patients with active TB 
that was correlated with mycobacterial load [47] and decreased 
TB-specific T-cell responses [42]. In our study, the changes in 
magnitude of CMV- and TB-specific CD4 T-cell responses on 
ART was strongly correlated with a reduction of PD-1 expres-
sion on effector memory CD4 T cells. Although, in this study, 
we did not measure PD-1 expression on antigen-specific cells, 
recent studies have shown that PD-1 expression is increased on 
TB-specific CD4 T cells from patients with active TB [47] and 
that blockade of the PD-1/PD-L pathway can recover cytokine 
and proliferative responses of these cells in vitro [42, 48]. In 
vitro antagonism of the PD-1/PD-L pathway was also shown 
to restore HIV- [49] and CMV-specific T-cell responses [45, 
46], pointing at new avenues for immunotherapy targeting the 
PD-1 pathway. However, modulation of the PD-1 pathway in 
patients with infectious diseases will need to be assessed care-
fully, as demonstrated by studies of PD-1 knockout mice that 
show increased pathology during MTB infection exacerbated 
by vigorous T-cell responses [50].
Our study has a number of important limitations. Due to the 
observational nature of the study, we can only report on correla-
tions between our findings. The number of cases in our study is 
relatively small, and our findings should be confirmed in larger 
cohorts. The follow-up period of this study was short consider-
ing the current prospects of lifelong ART for this population, 
and it calls for long-term follow-up studies, especially with a 
focus on immune activation for which we only observed little 
short-term impact of ART. The changes we observed in T-cell 
responses on ART were more pronounced in the CD4 T-cell 
compartment. Unfortunately, a more detailed study of CD4 
responses is currently constrained by the limited availability 
of reliable major histocompatibility complex class II tetramers, 
which would allow identification of antigen-specific CD4 T 
cells independent of cytokine responses upon in vitro stimula-
tion to allow unbiased characterization of these cells including 
measurements of PD-1 expression on tetramer-positive popula-
tions. Finally, this study was only limited to examine reconstitu-
tion of T-cell responses. Future studies should investigate other 
aspects of the immune system including humoral and innate 
immunity.
CONCLUSIONS
In summary, we demonstrate that children have great poten-
tial for reconstitution of HIV-specific and copathogen-specific 
immune responses that are associated with shifts in memory 
phenotype and PD-1 expression. Immune checkpoint inhibi-
tors that target the PD-1 pathway may represent a potential in-
tervention in patients with insufficient immune reconstitution 
on ART.
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